Tradestie Institutional Equity Comparison Engine
QNRX vs KPRX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
KPRX Overall Edge
KPRX Captures Institutional Edge (2โ1 Pillars ยท 4โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Kiora Pharmaceuticals, Inc. Common Stock (KPRX) driven by superior Valuation, Momentum & Technical while QNRX counters with relative strength in Growth & Margin. Fundamentally, QNRX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus KPRX at 1.7x Forward P/E and -890.2% operating margin (+0.0% YoY). In options structure, QNRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against KPRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
KPRX
QNRX N/M vs KPRX 1.7x Fwd P/E
Growth & Margin Winner
QNRX
Op Margin 0.0% vs -890.2% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
KPRX
1Y -82.0% vs -62.5% ยท 52W Pos 0% vs 0%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
QNRX
NASDAQ
Quoin Pharmaceuticals, Ltd. American Depositary Shares
Pharmaceutical Preparations
$3.28
-2.35% 1D
Market Cap
$16.1M
1M Return
-18.2%
1Y Return
-81.96%
Forward P/E
N/M
Unified AI Score
46.1 / 100
HOLD
Tech 38.0
Fund 47.0
Flow 50.0
Mom 64.0
KPRX
NASDAQ
Kiora Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$0.72
-12.28% 1D
Market Cap
$3.6M
1M Return
-68.96%
1Y Return
-62.49%
Forward P/E
1.7x
Unified AI Score
47.5 / 100
HOLD
Tech 45.0
Fund 46.0
Flow 50.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
QNRX -81.96%
KPRX -62.49%
Spread: +19.47 pp (KPRX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
QNRX TTM Op. Margin: 0.0%
KPRX TTM Op. Margin: -890.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on QNRX vs KPRX. Trailing 12-month operating profitability (QNRX 0.0% vs KPRX -890.2%) and valuation multiples (QNRX N/M vs KPRX 1.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | QNRX | KPRX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $16.1M | $3.6M | Larger Scale | QNRX |
| Trailing P/E Ratio Valuation | 7.6x | 1.7x | Lower Multiple | KPRX |
| Forward P/E Ratio Valuation | N/M | 1.7x | Lower Multiple | KPRX |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | -890.2% | Higher Margin | QNRX |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -142.6% | -67.7% | Higher ROE | KPRX |
| 52-Week Range Position Momentum | 0% ($3โ$24) | 0% ($1โ$3) | Stronger Trend | Tie |
| Beta / 30D Volatility Risk Regime | 1.34ฮฒ ยท 74% Vol | 1.62ฮฒ ยท 126% Vol | Lower Realized Risk | QNRX |
| Unified Institutional Score Composite Signal | 46.1 / 100 (HOLD) | 47.5 / 100 (HOLD) | Higher Composite | KPRX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full QNRX vs KPRX Buy Guide
QNRX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
KPRX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither QNRX nor KPRX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.